| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.8M | +0.0% |
| R&D Expense | $28.5M | -46.6% |
| SG&A Expense | $13.5M | -35.1% |
| Operating Income | -$42.1M | +63.6% |
| Pre-tax Income | -$39.6M | +65.5% |
| Income Tax | $0 | — |
| Net Income | -$39.6M | +65.5% |
| EPS (Basic) | -$4.60 | +85.2% |
| EPS (Diluted) | -$7.94 | +74.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.5M | -57.3% |
| Current Assets | $26.6M | -56.7% |
| Total Assets | $28.7M | -55.7% |
| Current Liabilities | $7.4M | -47.2% |
| Total Liabilities | $8.3M | -47.1% |
| Stockholders' Equity | $20.4M | +143.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$43.6M | +34.2% |
| Capital Expenditures | $133K | -9.5% |
| Investing Cash Flow | -$133K | -101.7% |
| Financing Cash Flow | $9.7M | -9.5% |
| Free Cash Flow | -$43.7M | +34.2% |